- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy.
September 22, 2023
Local Therapy on Clinically Lymph Node-positive Prostate Cancer: A Systematic Review and Meta-analysis.
September 22, 2023
Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: preliminary findings.
September 22, 2023
mpMRI-targeted biopsy of the prostate in men ≥ 75 years. 7-year report from a high-volume referral center.
September 22, 2023
Stereotactic body radiation therapy after radical prostatectomy: current status and future directions.
September 21, 2023
Work-related experiences of prostate cancer survivors in Australia: a qualitative study.
September 21, 2023
Ten-year work burden after prostate cancer treatment.
September 21, 2023
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models.
September 21, 2023
In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery.
September 20, 2023
Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification.
September 20, 2023
Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials.
September 20, 2023
Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRI.
September 19, 2023
Prostate Cancer Screening in African American Men: A Review of the Evidence.
September 19, 2023
Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer.
September 19, 2023